QBL /CGL will stand on it's own merits with Pharmocann, Canntab and Bonify ( and or any other joint ventures CBL can surprise shareholders with) to manufacture and export once federal licence comes in.
CGL will be it's own player, with possibilities having other joint ventures and major international companies buying in and not necessary take overs..(but then again merges have happened when least expected)
And perhaps with other major players with international investors to have an expansion of growing fields, here in Australia and in other countries with acres upon acres of hemp to provide hemp foods globally, produce high quality MM products globally, provide high quality recreational cannabis globally, and produce medical tablets globally and biomass extraction to other suppliers....
CGL is slowly spreading it's wings and when everything in the companies strategies aligns, producing revenue, others players will be looking in....
manifolds as I read in an announcement once....